Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Mf Beauty Partners LLC has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 4 distinct examiners and 3 distinct art units. This shows a variety of examiners relative to the number of pending matters, requiring a broad prosecution approach.
The busiest examiner is TRAN, SUSAN T, who handles 1 pending office action. Since there are 4 distinct examiners for the 4 pending actions, the workload is distributed across the examining staff. The involvement of 3 distinct art units within the Biotechnology & Pharmaceuticals area suggests that the company's filings are being evaluated across several specialized technical groups. Practitioners should be prepared to coordinate arguments across these 4 distinct examiners to maintain consistency in the company's patent disclosures. This distribution means that the company must manage four separate sets of examiner preferences and technical standards simultaneously.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PRAGANI, RAJAN | 1 | 52.4% | +71.4% |
| JOHNSON, DANIELLE D | 1 | 45.0% | +13.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17918826 | Anhydrous Azelaic Acid Topical Formulations | JOHNSON, DANIELLE D | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17918820 | High-Potency Vitamin C Chemical Peeling Solutions | PRAGANI, RAJAN | 12d |
| 17918826 | Anhydrous Azelaic Acid Topical Formulations | JOHNSON, DANIELLE D | — |
| Art Unit | Apps |
|---|---|
| 1614 | 1 |
| 1617 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17918820 | High-Potency Vitamin C Chemical Peeling Solutions | PRAGANI, RAJAN | 1614 | §103DP | Final Rejection | 12d | Pending | Oct 13, 2022 |
| 17918826 | Anhydrous Azelaic Acid Topical Formulations | JOHNSON, DANIELLE D | 1617 | §103§112Other | Non-Final OA | — | Pending | Oct 13, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMf Beauty Partners LLC has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Rajan Pragani has the most, with 1 of Mf Beauty Partners LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
